AGP Executive Report

Last update: 8 hours ago

NIH Influence Allegations: A whistleblower claims Bill Gates used large donations to the NIH via the Foundation for the National Institutes of Health to steer research priorities toward the Gates Foundation, raising questions about safeguards meant to block private influence. Obesity Drug Safety Debate: New reporting highlights concerns that rapid weight loss on GLP-1s may include substantial lean muscle loss, prompting calls to better protect muscle during treatment. UK Weight-Loss Pills Go Oral: Britain’s regulator approved Novo Nordisk’s oral Wegovy (semaglutide), giving patients a needle-free option and intensifying competition with Eli Lilly’s oral GLP-1 efforts. Biotech Market Volatility: Summit Therapeutics pulled a planned $500M secondary share offering after mixed Phase 3 results for ivonescimab, showing how clinical uncertainty can hit fundraising plans fast. Rare Disease & Pharma Deals: Chiesi completed its $1.9B acquisition of KalVista, adding EKTERLY for hereditary angioedema to its rare-disease portfolio. Cybersecurity & Staffing Pressure: A new piece warns ransomware targeting smaller health providers is rising, while a University of Michigan study finds COVID-era nurse job shifts were driven by burnout and staffing shortfalls. Public Health Reminder: World Pertussis Day coverage stresses whooping cough isn’t just a childhood disease and supports life-course vaccination, including during pregnancy.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Jun. 9, 2026

Caller ID Reputation launches healthcare eBook on patient call trust

EIN Presswire

fallback image
Jun. 5, 2026

Yilda M. Acevedo leads PharmPR and pushes for women in Puerto Rico pharma

EIN Presswire

fallback image
Jun. 4, 2026

Women’s health market seen reaching $60.99 billion by 2030

EIN Presswire

fallback image
Jun. 3, 2026

SGS launches GMP-compliant NMR testing for China pharma industry

EIN Presswire


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Pharma company sets sail for global markets with government-backed finance

Pharma company sets sail for global markets with government-backed finance

Growing AI Cybersecurity Challenges Facing The Healthcare Industry

Growing AI Cybersecurity Challenges Facing The Healthcare Industry

Axplora consolidates UDCA manufacturing at Vizag site

Axplora consolidates UDCA manufacturing at Vizag site

A San Antonio middle school is banking on the sports medicine industry

A San Antonio middle school is banking on the sports medicine industry

As featured in:

@ Journalists!

Join

No journalists yet — this is a new service area. Join today!

Journalists Wanted

fallback image
Jun. 10, 2026

Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight

GlobeNewswire, Inc.

fallback image
Jun. 9, 2026

Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight

GlobeNewswire, Inc.

fallback image
Jun. 9, 2026

Caller ID Reputation Releases New Healthcare Industry eBook on Strengthening Patient Communication and Trust

EIN Presswire

fallback image
15 hours ago

SAMHSA Announces $40 Million in Funding Opportunities to Prevent Addiction, and Address Child Trauma, Suicide, Mental Illness

SAMHSA

fallback image
17 hours ago

A&Es ‘bore the brunt’ as heatwave piled pressure on NHS

NHS England

fallback image
16 hours ago

NHS heroes recognised after accelerating cancer diagnosis and transforming patient care

NHS England

More press releases

Video Stories

YouTube video thumbnail: Doctor Explains why Bemotrizinol, a Sunscreen Ingredient, Took so Long to be Authorized
Play
Doctor Explains why Bemotrizinol, a Sunscreen Ingredient, Took so Long to be Authorized
YouTube video thumbnail: Why Some Experts are Concerned About Potential Health Risks During World Cup
Play
Why Some Experts are Concerned About Potential Health Risks During World Cup
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: How the Loss of USAID has Weakened the Fight Against Ebola
Play
How the Loss of USAID has Weakened the Fight Against Ebola
YouTube video thumbnail: Will Renaming PCOS Help Women get Diagnosed?
Play
Will Renaming PCOS Help Women get Diagnosed?

Video Title

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.